Corcept Therapeutics (CORT) Insider Trading & Ownership → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free cort Stock Alerts $22.19 -0.29 (-1.29%) (As of 03:15 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Corcept Therapeutics (NASDAQ:CORT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage19.80%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)16Amount OfInsider Selling(Last 12 Months)$8.24 M Get CORT Insider Trade Alerts Want to know when executives and insiders are buying or selling Corcept Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CORT Insider Buying and Selling by Quarter Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. Corcept Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/4/2024Joseph Douglas LyonInsiderSell5,443$26.00$141,518.00 4/1/2024Daniel N. Swisher, Jr.DirectorSell2,200$25.30$55,660.00 4/1/2024Joseph Douglas LyonInsiderSell500$26.01$13,005.00 3/27/2024Sean MaduckInsiderSell25,953$25.01$649,084.53 3/18/2024Sean MaduckInsiderSell17,219$25.00$430,475.00 3/1/2024Daniel N. Swisher, Jr.DirectorSell2,200$23.59$51,898.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/16/2024Joseph Douglas LyonCAOSell1,000$26.00$26,000.00 2/16/2024Sean MaduckInsiderSell27,068$25.97$702,955.96 2/1/2024Daniel N. Swisher, Jr.DirectorSell2,200$22.00$48,400.00 1/2/2024Daniel N. Swisher, Jr.DirectorSell2,200$22.11$48,642.00 12/22/2023William GuyerInsiderSell10,000$32.00$320,000.00 12/5/2023Gary Charles RobbInsiderSell1,381$26.27$36,278.87 12/4/2023Joseph Douglas LyonCAOSell2,432$26.00$63,232.00 12/1/2023Daniel N. Swisher, Jr.DirectorSell2,200$25.47$56,034.00 12/1/2023Joseph Douglas LyonCAOSell2,568$26.00$66,768.00 12/1/2023Sean MaduckInsiderSell25,000$25.56$639,000.00 11/2/2023Joseph Douglas LyonCAOSell3,977$28.11$111,793.47 11/1/2023Daniel N. Swisher, Jr.DirectorSell2,200$27.96$61,512.00 11/1/2023Sean MaduckInsiderSell5,112$28.08$143,544.96 10/10/2023Sean MaduckInsiderSell18,471$27.29$504,073.59 10/6/2023Joseph Douglas LyonCAOSell2,582$27.24$70,333.68 10/6/2023Sean MaduckInsiderSell3,498$27.24$95,285.52 10/2/2023Daniel N. Swisher, Jr.DirectorSell2,200$27.32$60,104.00 10/2/2023Joseph Douglas LyonCAOSell2,418$27.25$65,890.50 10/2/2023Sean MaduckInsiderSell3,031$27.24$82,564.44 9/19/2023Sean MaduckInsiderSell25,000$32.48$812,000.00 9/5/2023Daniel N. Swisher, Jr.DirectorSell2,200$32.90$72,380.00 9/1/2023Daniel N. Swisher, Jr.DirectorSell1,550$32.73$50,731.50 9/1/2023Joseph Douglas LyonCAOSell5,000$32.73$163,650.00 8/21/2023Joseph Douglas LyonCAOSell4,588$31.19$143,099.72 8/14/2023David L MahoneyDirectorSell25,000$30.95$773,750.00 8/14/2023Hazel HuntInsiderSell20,455$30.89$631,854.95 8/7/2023Daniel N. Swisher, Jr.DirectorSell2,850$30.14$85,899.00 8/7/2023Joseph Douglas LyonCAOSell412$31.22$12,862.64 6/6/2023Joseph Douglas LyonCAOSell10,000$23.60$236,000.00 5/9/2023Gary Charles RobbInsiderSell30,000$23.87$716,100.00 (Data available from 1/1/2013 forward) CORT Insider Trading Activity - Frequently Asked Questions Who is on Corcept Therapeutics's Insider Roster? The list of insiders at Corcept Therapeutics includes Daniel N Swisher Jr, Daniel N. Swisher, Jr., David L Mahoney, G Leonard Baker, Jr., Gary Charles Robb, Hazel Hunt, Joseph Douglas Lyon, Joseph K Belanoff, Sean Maduck, and William Guyer. Learn more on insiders at CORT. What percentage of Corcept Therapeutics stock is owned by insiders? 19.80% of Corcept Therapeutics stock is owned by insiders. Learn more on CORT's insider holdings. Which Corcept Therapeutics insiders have been selling company stock? The following insiders have sold CORT shares in the last 24 months: Daniel N. Swisher, Jr. ($591,260.50), David L Mahoney ($773,750.00), Gary Charles Robb ($4,293,157.43), Hazel Hunt ($631,854.95), Joseph Douglas Lyon ($1,114,153.01), Joseph K Belanoff ($7,353,183.16), Sean Maduck ($6,045,024.00), and William Guyer ($320,000.00). How much insider selling is happening at Corcept Therapeutics? Insiders have sold a total of 800,527 Corcept Therapeutics shares in the last 24 months for a total of $21,122,383.05 sold. More Insider Trading Tools from MarketBeat Related Companies: SUPN Insider Ownership AXSM Insider Ownership PCRX Insider Ownership XNCR Insider Ownership OPK Insider Ownership PRGO Insider Ownership AVIR Insider Ownership JAZZ Insider Ownership MRUS Insider Ownership SMMT Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:CORT) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Goldtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corcept Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.